Management of Elevated Creatinine

Immediate Assessment and Workup

For a patient with elevated serum creatinine, the American College of Cardiology recommends calculating the estimated glomerular filtration rate (eGFR) immediately using the MDRD equation, as serum creatinine alone significantly underestimates renal dysfunction in women and older adults, and this level likely represents chronic kidney disease stage 3 or worse (eGFR <60 mL/min/1.73 m²) 1
Evaluate for reversible causes within the first 48-72 hours, including checking for urinary obstruction via renal ultrasound, obtaining urinalysis to assess for proteinuria or signs of intrinsic renal disease, reviewing all medications for nephrotoxic agents, assessing volume status clinically, and checking electrolytes, particularly potassium and bicarbonate 2
Obtain spot urine albumin-to-creatinine ratio (ACR) as this has equivalent diagnostic and prognostic value to eGFR, and microalbuminuria or macroalbuminuria significantly increases cardiovascular disease risk and indicates need for aggressive management 3

Discontinue or dose-adjust nephrotoxic medications immediately, including stopping metformin if the patient is taking it, avoiding NSAIDs completely, exercising extreme caution with ACE inhibitors and ARBs, and not using aldosterone antagonists if creatinine is >2.0 mg/dL in women 1, 4, 5
Adjust all renally-cleared medications based on calculated eGFR rather than serum creatinine 1

Recheck creatinine and electrolytes within 3 days if any medication changes are made or if acute kidney injury is suspected 2
For stable chronic kidney disease, monitor serum creatinine and eGFR monthly for the first 3 months, then every 3 months thereafter, and monitor potassium levels, spot urine ACR, complete blood count, and calcium, phosphorus, and parathyroid hormone levels as indicated 1, 3, 5

Target blood pressure <130/85 mm Hg (ideally <130/80 mm Hg) in patients with renal disease, as inadequate blood pressure control is the primary modifiable risk factor for progression 3
Use ACE inhibitors or ARBs as preferred antihypertensive agents in chronic kidney disease with proteinuria, with appropriate dose adjustment and close monitoring 3

Refer to nephrology immediately if significant proteinuria (ACR >200 mg/g creatinine), unclear etiology of renal impairment, or difficulty managing complications is present 1
Establish co-management with nephrology within 3-6 months for stable chronic kidney disease with eGFR 30-60 mL/min/1.73 m² 1

Recognize that patients with chronic kidney disease have significantly elevated cardiovascular disease risk, and evaluate and aggressively manage all cardiovascular risk factors including lipids, diabetes, and smoking 1, 3

The European Heart Journal recommends stopping all nephrotoxic medications immediately, particularly NSAIDs, which cause diuretic resistance and worsen renal perfusion, and avoiding aldosterone antagonists if creatinine is >2.0 mg/dL in women or if significant hyperkalemia risk exists 6
The European Heart Journal suggests that ACE inhibitors or ARBs should not be discontinued prematurely, as creatinine increases up to 30% or <3.0 mg/dL are acceptable and represent hemodynamic changes rather than true kidney injury, and these medications are protective long-term and preferred antihypertensive agents in chronic kidney disease with proteinuria 6
The European Heart Journal recommends adjusting all renally-cleared medications based on calculated eGFR rather than serum creatinine alone, and reducing maintenance doses of drugs like digoxin to avoid toxicity 6
The European Heart Journal advises against using thiazide diuretics if creatinine clearance is <30 mL/min; loop diuretics are preferred 6

Intrinsic renal parenchymal disease, including glomerulonephritis, interstitial nephritis, or chronic kidney disease from hypertension, diabetes, or other causes, remains possible, according to Clinical Infectious Diseases 7
Vascular causes, including renal artery stenosis, are also possible, as noted by the European Heart Journal 6